Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard Versus Short Course Prophylactic Antibiotic in Femur and Tibia Shaft Fractures
NCT07554079Completed
- Sponsor
- Kathmandu University School of Medical Sciences
- Start
- Feb 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cefuroxime in surgical site infection (SSI) (2 arms), sponsored by Kathmandu University School of Medical Sciences. Primary endpoint: Incidence of Wound Infection based on ASEPSIS score at 6 weeks. Started Feb 2024; status: completed.
02
Drugs
cefuroxime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07554079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07554079.